<DOC>
	<DOCNO>NCT00952952</DOCNO>
	<brief_summary>Subjects must 18 year old old , diarrhea microscopic colitis . Pregnant nursing female exclude . They ca n't untreated diarrheal condition . Subjects receive medication 8 week , follow sigmoidoscopy biopsy . The subject monitor weekly . A pathologist review pre post treatment biopsy . Subjects show improvement follow 4 week post medication .</brief_summary>
	<brief_title>Trial Mesalamine Treatment Active Microscopic Colitis</brief_title>
	<detailed_description>We propose prospective , randomized trial mesalamine 1.2g 4.8g dos treatment microscopic colitis . Our hypothesis mesalamine safe effective treatment diarrhea microscopic colitis 4.8g dose effective 1.2g dose . We recruit 70 subject . The subject randomize two group , 4.8g dose , 1.2g dose group . Subjects receive medication 8 week , follow sigmoidoscopy biopsy . The subject monitor weekly . A pathologist review pre post treatment biopsy . Responders follow 4 week post medication . Subjects must 18 year old old , diarrhea microscopic colitis . Subjects exclude unsuccessful treatment side effect 5-ASA drug , oral corticosteroid , salicylate . antibiotic , mesalamine , bismuth steroid use last two week . Subjects may anticholinergics , cholestyramine , digoxin . Pregnant nursing female exclude . They ca n't untreated diarrheal condition . A two-sample z-score test proportion use test whether relief rate different group .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Colitis , Microscopic</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Subjects must 18 year old old . Have diarrhea microscopic colitis . They need colon biopsy do Mayo Clinic Rochester , MN within year enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>